Physicians Are People First. Prescribers Second.
Stay Informed
Get insights delivered to your inbox
Subscribe to receive the latest research, perspectives, and strategic insights from Shapiro+Raj.
Somewhere in a pharma brand meeting happening right now, someone is saying the words “we need twenty-four HCPs.”
- A quota.
- A slot to be filled.
- Pharma often treats physicians as a sample, not as people.
- We've Spent Decades Studying HCPs Without Understanding Them.
Pharma knows more about what HCPs do than almost any industry knows about its audience. Prescribing volume. Specialty. Reach. Frequency. Channel behavior.
What it knows far less about is why.
Why this cardiologist favors a familiar molecule even when the data supports a newer one. Why that oncologist, who intellectually endorses a treatment, rarely reaches for it in practice. Why the same message that moves one rheumatologist leaves another completely unmoved.
The gap between stated behavior and actual behavior in HCP research is not a data quality problem.
It is a framing problem.
When research is designed around the HCP-as-respondent model, we get the rational account. We miss the operating belief underneath it.
The Default Assumption Is That HCPs Are Essentially Alike.
That is how physicians get flattened before the work even starts.
The physician who entered oncology because they lost someone to cancer. The internist who trained in an under-resourced system and has spent twenty years calibrating their skepticism of pharmaceutical claims. The rheumatologist who sits on advisory boards and has built an exacting mental model of how new therapies earn their confidence. The hospitalist who sees thirty patients a day and makes prescribing calls in the space between two hallway conversations.
We treat these people as interchangeable until a segmentation effort forces us to see the differences.
And even then, we often stop at behavioral clusters. Prescribing volume. Practice type. Specialty. Variables that describe what HCPs have done rather than who they are.
Even the most evidence-driven clinicians routinely operate through cognitive shortcuts under real-world pressure.
Familiarity bias. Status quo bias. Availability heuristics.
This is the brain’s natural architecture for managing complexity in decision-making. And they are nearly invisible to any study design that asks physicians only to reflect on their own decision-making.
We’re asking the wrong questions.
The Person Behind the Prescriber Is the Point.
Every physician in your study chose this field for a reason.
They formed clinical intuitions through formative experiences in training. They hold professional beliefs — sometimes explicit, often not — about what kinds of risk are acceptable for what kinds of patients. They’re influenced by peers in ways they may not consciously register. They carry different emotional bandwidth into a conversation at 9am than they do at 4pm when they’re running two hours behind.
Beliefs, ambitions, fears, professional identity, peer relationships, the stories physicians tell themselves about what good medicine looks like are real insights, real data points. They shape how HCPs interpret clinical evidence, how they respond to brand messaging, and ultimately, whether they reach for a new therapy or the one they already know.
What Changes When You Lead With the Human.
Messaging built on a genuine understanding of physician identity outperforms messaging built on clinical benefit logic.
A claim that connects to a pulmonologist’s heroic ambition to save lives is not the same intervention as one that speaks to their pragmatic concern about not harming a frail patient.
A large respiratory brand put this to the test. A multi-market physician study went looking for drivers and barriers and found something more uncomfortable: a new set of foundational beliefs about the disease category that was driving prescribing behavior.
The prior research had never uncovered these underlying motivators because prior research had never created the conditions to find them. The work reshaped how the team thought about provider engagement and was the backbone of informing the brand’s messaging.
That finding is not unique to respiratory.
Over the last five years, we built the PROsician™ model — a framework that segments HCPs not by what they prescribe, but by where they stand on two dimensions that actually predict behavior: their orientation toward clinical innovation, and the depth of their therapeutic expertise.
The result is four distinct physician archetypes, each with a different relationship to evidence, risk, and change. They don’t behave the same way. They don’t respond to the same message. And they can’t be engaged with the same strategy.
The Industry Has a Choice to Make.
- Patient centricity was the right move.
- It was just incomplete.
- The same human truth that unlocked better strategy for patients is waiting to unlock better strategy for HCPs.
Physicians are more than the delivery mechanism for the patient’s care. They are human beings making complex decisions under uncertainty — shaped by their history, their professional identity, their peer relationships, and a clinical culture that rewards certain kinds of thinking.
Twenty-four HCPs is a quota.
Understanding twenty-four humans is a strategy. And a faster path to market.
Every round of messaging iteration you skip because you understood the physician before you built the brief is time you get back.
Are you building a strategy — or just filling a quota?
Contact: communications@shapiroraj.com